Menu Close
Research associate, Warren Alpert Medical School, Brown University, Brown University

Sanjay is the project coordinator for the "COVID-19 and Cancer Consortium", (CCC19) consisting of over 125 cancer centers and other organizations that have come together to collect data about cancer patients who have been infected with COVID-19. Previously, Sanjay worked as a postdoctoral fellow in Vanderbilt Vaccine Center, where he tried to develop vaccine candidates against Zika and Dengue. He got his Ph.D. from Vanderbilt University in Chemical and Physical Biology, studying small heat shock proteins (sHSPs) for their role in the stress response and aging. Using protein engineering and CRISPR knockout strategies, Sanjay showed that sHSPs have conserved roles among vertebrates, and sHSPs have evolved possibly under the organellar and organismic proteostatic demands. When not in lab, Sanjay moonlights as a popular science writer.

Experience

  • 2022–present
    Research associate, Brown University
  • 2022–present
    Research Program Manager, Lifespan Health; Rhode Island Hospital
  • 2020–2022
    Staff Scientist, Vanderbilt University Medical Center
  • 2018–2020
    Postdoctoral Scholar of Pathology, Microbiology, and Immunology, Vanderbilt University

Education

  • 2018 
    Vanderbilt University, Ph.D.
  • 1995 
    Indian Institute of Technology, M.Tech.

Publications

  • 2022
    COVID-19 vaccination and breakthrough infections in patients with cancer. ,
  • 2022
    Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States. ,
  • 2022
    Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies. ,
  • 2022
    Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. ,
  • 2022
    COVID-19 Vaccine Among Actively-Treated People With Cancer: A Glimpse Into the Known Unknowns?,
  • 2022
    Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.,
  • 2022
    Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.,
  • 2022
    Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium.,
  • 2022
    Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19. ,
  • 2022
    Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19,
  • 2021
    COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response. ,
  • 2021
    The COVID-19 & Cancer Consortium (CCC19) and Opportunities for Radiation Oncology. ,
  • 2021
    Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.,
  • 2021
    Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19. ,
  • 2021
    Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal Cancer. ,
  • 2021
    Care without a compass: Including patients with cancer in COVID-19 studies. ,
  • 2021
    The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. ,
  • 2021
    Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19. ,
  • 2020
    Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. ,
  • 2020
    A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance. ,
  • 2020
    Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. ,

Professional Memberships

  • American Association for Cancer Research